Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2020 Earnings Conference Call November 9, 2020 4:30 PM ET Company Participants Jack Hildick-Smith - Stern IR Derek Chalmers - President and CEO Thomas Reilly - CFO Conference Call Participants Zach Sachar - Piper Sandler Nick Rubino - Stifel Chi Meng Fong - BAnk of America Alan Carr - Needham & Company Ben Shim - Canaccord Operator Good afternoon and welcome to Cara Therapeutics' Third Quarter 2020 Financial Results Conference Call. All participants are now in list ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75-3175693 (State or other jurisdiction of incorporation ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Jack Hildick-Smith - Stern IR Derek Chalmers - President and CEO Rick Makara - VP and Head, Accounting Conference Call Participants Chris Howerton - Jefferies David Amsellem - Piper Sandler Annabel Samimy - Stifel Jason Gerberry - Bank of America Alan Carr - Needham & Company Operator Good afternoon and welcome to Cara Therapeutics' Second Quarter 2020 Financial Results Conference Call. All ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75-3175693 (State or other jurisdiction of incorporation or or ...

Targeting Pruritus with Novel Peripherally-Restricted Kappa Agonist Therapeutics May 2020 Forward Looking Statements 2 This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the words "anticipate," "believe," "continue," "estimate," "expect," "objective," "ongoing," "plan," "propose," "potential," "projected", or "up-coming" and/or the negative of these terms, or o ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Jack Hildick-Smith - Stern Investor Relations Derek Chalmers - President & Chief Executive Officer Rick Makara - Vice President & Head of Accounting Conference Call Participants Jason Gerberry - Bank of America David Amsellem - Piper Sandler Chris Howerton - Jefferies Alan Carr - Needham & Company Esther Hong - Janney Operator Good afternoon and welcome to Cara Therapeutics First Quarter 2020 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75-3175693 (State or other jurisdiction of incorporation or o ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2019 Earnings Conference Call February 27, 2020 4:30 PM ET Company Participants Jack Hildick-Smith - Stern Investor Relations Derek Chalmers - President and Chief Executive Officer Rick Makara - Vice President and Head, Accounting Conference Call Participants Chris Howerton - Jefferies David Amsellem - Piper Sandler Annabel Samimy - Stifel Chi Meng Fong - Bank of America Pete Stavropoulos - Cantor Fitzgerald Ben Shim - Canaccord Esther Hong - Janney Operator Good aft ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001‑36279 CARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 75‑3175693 (State or other jurisdiction of incorporation or organ ...

Targeting Pruritus with Novel Peripherally-Restricted Kappa Agonist Therapeutics November 2019 Forward Looking Statements 2 This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the words "anticipate," "believe," "continue," "estimate," "expect," "objective," "ongoing," "plan," "propose," "potential," "projected", or "up-coming" and/or the negative of these terms, ...